Sangamo Therapeutics, Inc. Financial Ratios — GBY.DE Stock

Profitability (USD)

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-23.94	-33.04	-47.56	-26.21	-23.84	-13.76	-17.68	-38.2	-24.55	-15.58	-15.5	-15.35	-21.47	-29.94	-70.85
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-84.87	-116.6	-340.88	-99.46	-108.3	-57.19	-116.01	-369.09	-150.03	-88.56	-93.31	-98.3	-149.68	-162.37	-54.93
Operating Margin (%)	-87.45	-119.85	-347.14	-102.51	-110.66	-58.38	-118.51	-374.23	-154.13	-91.35	-102.69	-109.61	-165.61	-180.85	-67.52
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-346.45	-102.81	-110.32	-57.59	-117.42	-369.65	-149.23	-81.57	-93.16	-102.19	-160.79	-172.37	-149.18
Profit Margin (%)	-83.77	-119.46	-346.45	-102.81	-110.32	-57.59	-102.94	-369.58	-149.23	-80.91	-92.93	-102.37	-161.05	-172.76	-146.3
Net Income to Common Margin (%)	-83.77	-119.46	-346.45	-102.81	-110.32	-57.59	-102.94	-369.58	-149.23	-80.91	-92.93	-102.37	-161.05	-172.76	-146.3
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Debt	- -	- -	- -	- -	- -	- -	- -	4	25	28	44	42	48	43	38
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4	4	4	5
LT Debt	- -	- -	- -	- -	- -	- -	- -	4	25	28	41	38	44	39	34
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.06	-0.45	-0.37	-0.46	-0.36	-0.29	-0.24	-0.39
Net Debt/EBITDA	1.12	0.44	0.48	1.01	0.39	0.23	1.51	0.31	0.91	1.88	0.84	1.13	1.08	0.56	0.47
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.05	-0.44	-0.36	-0.42	-0.32	-0.26	-0.21	-0.32
Net Debt/EBIT	1.09	0.43	0.47	0.98	0.38	0.23	1.48	0.3	0.88	1.82	0.76	1.01	0.98	0.5	0.38
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-219.8	-344.51	-289.36	-333.17	-214.08	-134.8	-169.65	-278.8	-172.5	-95.14	-102.87	-82.74	-132.26	-203.89	-849.62
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.9	13.17	7.54	9.52	7.72	11.74	13.22	40.43
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-6.74	-5.22	-4.86	-3.53	-2.45
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.46	4.09	6.1	6.93	20.27
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.9	13.17	7.54	10.26	8.46	12.81	14.61	45.97
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-7.26	-5.72	-5.3	-3.91	-2.79
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.97	4.48	6.66	7.66	23.05
Net Debt to Equity	-29.48	-19.29	-20.92	-33.41	-8.37	-2.92	-36.11	-16.2	-26.52	-38.23	-18.59	-26.4	-47.66	-34.05	-54.54
Net Debt/Capital (%)	9.92	4.73	6.22	7.31	3.27	1.81	15.86	4.81	9.59	20.84	11.63	15.15	16.48	8.34	3.2
EBITDA	-19	-24	-35	-22	-26	-26	-46	-72	-55	-75	-96	-116	-166	-181	-97
EBITDA-CapEx	-19	-25	-36	-22	-27	-26	-46	-72	-59	-118	-116	-131	-189	-201	-118
Operating Income (Loss)	-19	-25	-36	-22	-27	-27	-47	-73	-56	-77	-105	-130	-183	-201	-119

Liquidity (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Cash Ratio	5.43	8.5	11.68	7.23	9.16	8.57	10.4	10.72	5.42	5.1	5.19	4.47	2.94	2.49	1.7
Current Ratio	5.48	8.65	11.9	7.78	9.6	9.14	10.58	11.25	5.54	5.23	5.8	4.6	3.12	2.69	1.98
Quick Ratio	5.45	8.6	11.85	7.72	9.51	9.09	10.54	11.12	5.5	5.16	5.73	4.51	2.99	2.53	1.72
CFO/Avg Current Liab	-0.45	-2.1	-3.62	-1.01	-2.06	-0.37	-1.65	-3.95	0.38	0.59	-1.95	1.59	-1.72	-1.87	-2.82
Common Equity/Total Assets	-219.8	-344.51	-289.36	-333.17	-214.08	-134.8	-169.65	-278.8	-172.5	-95.14	-102.87	-82.74	-132.26	-203.89	-849.62
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.9	13.17	7.54	9.52	7.72	11.74	13.22	40.43
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-6.74	-5.22	-4.86	-3.53	-2.45
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.46	4.09	6.1	6.93	20.27
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.9	13.17	7.54	10.26	8.46	12.81	14.61	45.97
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-7.26	-5.72	-5.3	-3.91	-2.79
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.97	4.48	6.66	7.66	23.05
CFO/Total Liabilities	-39.2	-337.48	-359.45	-45.82	-101.85	-15.51	-135.99	-303.66	11.31	16.38	-70.52	38.5	-67.3	-83.58	-272.76
CFO/CapEx	-22.56	-34.44	-44.96	-11.18	-45.1	- -	- -	-90	2.98	0.85	-6.98	11.55	-10.02	-11.09	-10.63
Altman's Z-Score	5.02	22.85	6.58	5.58	7.44	4.4	5.93	4.35	0.3	0.13	0.15	2.19	-0.44	-4.08	-12.88

Working Capital (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Accounts Receivable Turnover	77.99	95.66	16.06	8.58	6.63	6.78	6.14	5.18	8.8	21.07	4.93	5.61	19.7	22.97	76.61
Days Sales Outstanding	4.68	3.82	22.73	42.54	55.08	53.8	59.49	70.53	41.5	17.32	74.09	65.06	18.53	15.89	4.76
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Market Capitalization	199	326	130	294	326	344	322	313	396	468	530	2,296	1,133	- -	- -
- Cash & Cash Equivalents	21	11	17	22	10	6	69	22	50	140	80	131	179	100	45
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	-1	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	4	25	28	44	42	48	43	38
Enterprise Value	114	266	45	231	233	165	113	175	177	96	212	1,695	804	-235	-43
Total Capital	-192	-217	-253	-275	-302	-328	-369	-436	-470	-533	-611	-735	-907	-1,104	-1,366
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.9	-5.26	-5.19	-7.26	-5.72	-5.3	-3.91	-2.79
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.02	0.14	0.29	0.21	0.02	0.06	-0.18	-0.89
EV/Sales	5.14	12.8	4.41	10.65	9.66	3.6	2.85	9	4.84	1.14	2.07	14.34	7.27	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	15.83	2.63	- -	9.98	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	11.86	1.21	- -	9.19	- -	- -	- -
Diluted Market Cap	199	326	130	294	326	344	322	313	396	468	530	2,296	1,133	- -	- -
Diluted Enterprise Value	178	316	113	273	316	338	252	295	370	356	494	2,206	1,002	-57	-7
EV per Share	2.71	5.89	0.9	4.37	4.16	2.46	1.62	2.47	2.27	0.99	1.89	12.61	5.56	- -	- -
TTM Sales	22	21	10	22	24	46	40	19	37	84	102	118	111	111	176
TTM EBITDA	-19	-24	-35	-22	-26	-26	-46	-72	-55	-75	-96	-116	-166	-181	-97
TTM Operating Income	-19	-25	-36	-22	-27	-27	-47	-73	-56	-77	-105	-130	-183	-201	-119
TTM Cash Flow to Firm	- -	- -	-26	-8	-19	-6	-34	-66	11	37	-144	170	-233	-224	-225
TTM Free Cash Flow to Firm	- -	- -	-25	-7	-19	-6	-34	-65	15	80	-124	185	-210	-203	-204

Multiples (USD)

API ChatGPT

	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Price/Free Cash Flow	-33.92	-14.05	-5.12	-39.98	-17.11	-60.6	-9.54	-4.81	26.5	5.88	-4.28	12.44	-5.39	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	114	266	45	231	233	165	113	175	177	96	212	1,695	804	-235	-43
Low Price	2.19	3.17	2.39	2.56	5.39	5.13	4.43	4.38	4.39	4.73	4.6	4.71	7.11	3.15	- -
EV/Sales	5.14	12.8	4.41	10.65	9.66	3.6	2.85	9	4.84	1.14	2.07	14.34	7.27	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-6.14	-8.64	-8.03	-11.58	-11.78	-14.24	-8.03	-4.6	-6.82	-7.07	-5.56	-10.84	-8.82	- -	- -
Price/Earnings High	-12.87	-13.39	-12.78	-13.82	-12.25	-14.92	-8.68	-4.79	-7.27	-7.49	-5.74	-21.28	-14.32	- -	- -
Price/Earnings Low	-4.96	-5.77	-3.38	-6.07	-11.34	-13.01	-7.59	-4.32	-6.28	-6.72	-5.42	-5.24	-5.77	- -	- -
Price/Book Value	-1.04	-1.5	-0.51	-1.07	-1.08	-1.05	-0.87	-0.71	-0.8	-0.83	-0.81	-2.96	-1.19	- -	- -
Price/Book Value Average	-0.59	-0.99	-1.14	-0.94	-1.04	-1.15	-0.89	-0.75	-0.75	-0.86	-0.81	-1.69	-1.65	- -	- -
Price/Book Value High	-1.24	-1.53	-1.81	-1.12	-1.08	-1.2	-0.96	-0.78	-0.8	-0.91	-0.83	-3.32	-2.67	- -	- -
Price/Book Value Low	-0.48	-0.66	-0.48	-0.49	-1	-1.05	-0.84	-0.7	-0.69	-0.82	-0.79	-0.82	-1.08	- -	- -
Price/Tangible Book Value	2.77	5.84	1.62	4.53	2.76	1.69	1.69	2.33	2.12	1.71	1.56	5.79	4.02	- -	- -
Price/Tangible Book Value Average	1.59	3.84	3.58	3.97	2.65	1.85	1.71	2.45	2	1.77	1.56	3.31	5.58	- -	- -
Price/Tangible Book Value High	3.33	5.95	5.7	4.74	2.76	1.94	1.85	2.55	2.13	1.87	1.6	6.5	9.06	- -	- -
Price/Tangible Book Value Low	1.28	2.56	1.51	2.08	2.55	1.69	1.62	2.3	1.84	1.68	1.51	1.6	3.65	- -	- -
Price/Sales	8.97	15.69	12.56	13.58	13.51	7.5	8.14	16.15	10.82	5.54	5.17	19.42	10.23	- -	- -
Price/Sales Average	5.15	10.32	27.83	11.9	13	8.2	8.26	17	10.18	5.72	5.17	11.1	14.2	- -	- -
Price/Sales High	10.78	15.99	44.26	14.2	13.51	8.59	8.93	17.7	10.84	6.06	5.33	21.79	23.06	- -	- -
Price/Sales Low	4.16	6.89	11.72	6.24	12.51	7.49	7.81	15.95	9.38	5.43	5.03	5.36	9.29	- -	- -
Price/Cash Flow	-32.42	-13.64	-5.01	-36.4	-16.73	-60.6	-9.54	-4.75	35.39	12.8	-3.67	13.51	-4.86	- -	- -
Price/Cash Flow Average	-18.61	-8.97	-11.09	-31.9	-16.1	-66.27	-9.69	-5	33.31	13.22	-3.67	7.72	-6.74	- -	- -
Price/Cash Flow High	-38.97	-13.9	-17.64	-38.06	-16.73	-69.44	-10.48	-5.21	35.47	14	-3.78	15.16	-10.94	- -	- -
Price/Cash Flow Low	-15.02	-5.99	-4.67	-16.71	-15.49	-60.56	-9.16	-4.69	30.67	12.56	-3.57	3.73	-4.41	- -	- -
Price/Free Cash Flow Average	-19.47	-9.24	-11.34	-35.03	-16.47	-66.27	-9.69	-5.06	24.94	6.07	-4.28	7.11	-7.49	- -	- -
Price/Free Cash Flow High	-40.77	-14.32	-18.04	-41.8	-17.11	-69.44	-10.48	-5.27	26.56	6.43	-4.41	13.95	-12.16	- -	- -
Price/Free Cash Flow Low	-15.72	-6.17	-4.78	-18.35	-15.84	-60.56	-9.16	-4.75	22.96	5.76	-4.17	3.43	-4.9	- -	- -
EV/Sales Average	4.19	9.8	26.2	10.9	12.58	8.07	6.51	16.06	9.5	4.39	4.82	10.34	13.02	- -	- -
EV/Sales High	9.82	15.47	42.64	13.2	13.09	8.46	7.18	16.77	10.16	4.73	4.98	21.03	21.88	- -	- -
EV/Sales Low	3.2	6.37	10.1	5.24	12.09	7.36	6.05	15.01	8.69	4.11	4.68	4.6	8.1	- -	- -
EV/EBITDA Average	-4.94	-8.41	-7.69	-10.96	-11.61	-14.11	-5.61	-4.35	-6.33	-4.96	-5.17	-10.52	-8.7	0.32	0.07
EV/EBITDA High	-11.58	-13.27	-12.51	-13.27	-12.08	-14.79	-6.19	-4.54	-6.77	-5.34	-5.34	-21.39	-14.62	0.32	0.07
EV/EBITDA Low	-3.77	-5.46	-2.96	-5.26	-11.16	-12.87	-5.22	-4.07	-5.79	-4.64	-5.02	-4.68	-5.41	0.32	0.07
EV/EBIT Average	-4.8	-8.18	-7.55	-10.64	-11.36	-13.82	-5.49	-4.29	-6.16	-4.81	-4.69	-9.43	-7.86	0.28	0.06
EV/EBIT High	-11.23	-12.91	-12.28	-12.88	-11.83	-14.49	-6.06	-4.48	-6.59	-5.18	-4.85	-19.18	-13.21	0.28	0.06
EV/EBIT Low	-3.66	-5.32	-2.91	-5.11	-10.92	-12.61	-5.11	-4.01	-5.64	-4.5	-4.56	-4.2	-4.89	0.28	0.06
Last Price	4.73	7.23	2.57	5.58	5.82	5.13	4.61	4.44	5.07	4.83	4.73	17.07	7.84	5.21	- -
High Price	5.69	7.37	9.04	5.83	5.82	5.88	5.06	4.87	5.08	5.28	4.87	19.15	17.66	7.95	- -
Enterprise Value Average	93	204	270	236	304	370	257	311	347	371	494	1,222	1,441	-57	-7
Enterprise Value High	218	322	440	286	316	388	284	325	371	400	510	2,485	2,422	-57	-7
Enterprise Value Low	71	133	104	113	292	338	239	291	318	347	480	544	897	-57	-7

Shares Outstanding	45	45	53	53	62	69	70	71	86	102	116	142	146	167	178
Diluted Weighted Avg Shares	42	45	51	53	56	67	70	71	78	97	112	134	145	- -	- -
Basic Weighted Avg Shares	42	45	51	53	56	67	70	71	78	97	112	134	145	- -	- -
Revenue per Share	0.53	0.46	0.2	0.41	0.43	0.68	0.57	0.27	0.47	0.87	0.91	0.88	0.77	- -	- -
EBITDA per Share	-0.45	-0.54	-0.7	-0.41	-0.47	-0.39	-0.66	-1.01	-0.7	-0.77	-0.85	-0.86	-1.15	- -	- -
Operating Income per Share	-0.46	-0.55	-0.71	-0.42	-0.48	-0.4	-0.67	-1.03	-0.72	-0.8	-0.94	-0.96	-1.27	- -	- -
Basic EPS, GAAP	-0.44	-0.55	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.7	-0.85	-0.9	-1.23	- -	- -
Basic EPS from Cont Ops	-0.44	-0.55	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.71	-0.85	-0.9	-1.23	- -	- -
Diluted EPS, GAAP	-0.44	-0.55	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.7	-0.85	-0.9	-1.23	- -	- -
Diluted EPS from Cont Ops	-0.44	-0.55	-0.71	-0.42	-0.48	-0.39	-0.58	-1.02	-0.7	-0.71	-0.85	-0.9	-1.23	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.15	-0.53	-0.51	-0.15	-0.35	-0.08	-0.48	-0.93	0.14	0.38	-1.29	1.26	-1.61	- -	- -
Free Cash Flow per Basic Share	-0.15	-0.55	-0.52	-0.17	-0.36	-0.08	-0.48	-0.94	0.1	-0.07	-1.47	1.15	-1.77	- -	- -
Cash & Equivalents per Share	2.02	1.33	1.67	1.2	1.66	2.67	3	2.02	3.12	4.13	3.23	4.77	2.6	- -	- -
Book Value per Share	-4.57	-4.81	-5	-5.21	-5.39	-4.89	-5.28	-6.24	-6.33	-5.79	-5.85	-5.78	-6.6	- -	- -
Tangible Book Value per Share	1.71	1.24	1.59	1.23	2.11	3.03	2.74	1.91	2.39	2.82	3.04	2.95	1.95	- -	- -

Sangamo Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)